Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randall Johnson

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
Cantuzumab mertansine, a maytansinoid immunoconjugate directed to the CanAg antigen: a phase I, pharmacokinetic, and biologic correlative studyAnthony W Tolcher, Leonel Ochoa, Lisa A Hammond, et al.
Science Advances|March 25, 2026
Blood feeding triggers the terminal differentiation of precursor cells in tick salivary glandsSazzad Mahmood, Stephen Lu, Ana Beatriz Barletta Ferreira, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
Transcriptome and Functions of Granulocytic Myeloid-Derived Suppressor Cells Determine their Association with Disease Severity of COVID-19Matthew J Dean, Juan B Ochoa, Maria Sanchez-Pino, et al.
Frontiers in Immunology|August 3, 2021
Severe COVID-19 Is Characterized by an Impaired Type I Interferon Response and Elevated Levels of Arginase Producing Granulocytic Myeloid Derived Suppressor CellsMatthew J Dean, Juan B Ochoa, Maria Dulfary Sanchez-Pino, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
Cantuzumab mertansine, a maytansinoid immunoconjugate directed to the CanAg antigen: a phase I, pharmacokinetic, and biologic correlative studyAnthony W Tolcher, Leonel Ochoa, Lisa A Hammond, et al.
Science Advances|March 25, 2026
Blood feeding triggers the terminal differentiation of precursor cells in tick salivary glandsSazzad Mahmood, Stephen Lu, Ana Beatriz Barletta Ferreira, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
Transcriptome and Functions of Granulocytic Myeloid-Derived Suppressor Cells Determine their Association with Disease Severity of COVID-19Matthew J Dean, Juan B Ochoa, Maria Sanchez-Pino, et al.
Frontiers in Immunology|August 3, 2021
Severe COVID-19 Is Characterized by an Impaired Type I Interferon Response and Elevated Levels of Arginase Producing Granulocytic Myeloid Derived Suppressor CellsMatthew J Dean, Juan B Ochoa, Maria Dulfary Sanchez-Pino, et al.
Pageof 2